Is Ecto-nucleoside Triphosphate Diphosphohydrolase (NTPDase)-based Therapy of Central Nervous System Disorders Possible?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|15|1|5-20

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.15, Iss.1, 2015-01, pp. : 5-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging applications of hormonal therapy of paroxysmal central nervous system disorders

By Klein P.   Herzog A.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1337-1350

Informa Healthcare

Access to resources Recommend Favorite

Delivery of Anti-Viral Nucleoside Analogues to the Central Nervous System

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 1, Iss. 1, 2002-01 ,pp. : 55-63

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Flavonoids in Central Nervous System Disorders

By  

Current Medicinal Chemistry, Vol. 20, Iss. 37, 2013-11 ,pp. : 4694-4719

Bentham Science Publishers

Access to resources Recommend Favorite

Autophagy in the Central Nervous System: Implications for Neurodegenerative Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 701-719

Bentham Science Publishers

Access to resources Recommend Favorite

Thromboregulatory potential of endothelial CD39/nucleoside triphosphate diphosphohydrolase: modulation of purinergic signalling in platelets

By Robson S.C.   Sévigny J.   Imai M.   Guckelberger O.   Enjyoji K.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 2, 2000-04 ,pp. : 155-171

Informa Healthcare

Access to resources Recommend Favorite